Maze Therapeutics MAZE
NASDAQ MAZE
$32.58 +0.13 (+0.40%)
At close: Oct 21, 2026 · 4:00 PM EDT

Maze Therapeutics (MAZE) Interest Expenses (2026)

Updated

Maze Therapeutics' Interest Expenses was $931,000 in Q2 2026, up 7.5% from the prior quarter.

Analysis

Maze Therapeutics (MAZE) Interest Expenses (2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int Expense (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn -
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 281.00 Mn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 462.00 Mn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 435.00 Mn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 673.00 Mn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 247.00 Mn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 Maze Therapeutics 1.92 Bn 434.24 Mn - 931,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 931,000.00
Mar 31, 2026 866,000.00
API Access

Maze Therapeutics Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-expenses&ticker=MAZE&period=max&api_key=YOUR_API_KEY